Enhancing Cognitive and Neurobehavioral Functions After Repetitive Traumatic Brain Injuries (rTBI) in Retired NFL Players and Military Veterans.

Sponsor
Brain & Body Health Foundation (Other)
Overall Status
Unknown status
CT.gov ID
NCT02699476
Collaborator
(none)
60
1
3
22
2.7

Study Details

Study Description

Brief Summary

The purpose of this study is to compare different combinations of cognitive training in retired professional football players and military veterans with a history of repeated concussions and persistent symptoms of impaired memory, concentration, attention, focus, or thinking.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Psycho-Social Therapy
  • Device: Cognitive Behavioral Computer Training
  • Behavioral: Interactive Trainer-Subject Sessions
  • Device: Active Control Games
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Enhancing Cognitive and Neurobehavioral Functions After Repetitive Traumatic Brain Injuries (rTBI) in Retired NFL Players and Military Veterans.
Study Start Date :
Feb 1, 2016
Anticipated Primary Completion Date :
Sep 1, 2017
Anticipated Study Completion Date :
Dec 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Individual + Computer A

Daily activities involve playing one hour of computer games (e.g., hangman, boggle, word scramble, chess; computer cognitive training A (CCA)), and two (2) 90 minute individual training sessions interacting one-on-one with a trainer in a variety of cognitive tasks including attention, memory, and comprehension of information.

Behavioral: Interactive Trainer-Subject Sessions
Other Names:
  • LearningRx
  • Device: Active Control Games

    Experimental: Individual + Computer B

    Daily activities involve playing an alternative set of computer games (computer cognitive training B (CCB)), and two (2) 90 minute individual training sessions interacting one-on-one with a trainer in a variety of cognitive tasks including attention, memory, and comprehension of information.

    Device: Cognitive Behavioral Computer Training
    Other Names:
  • BrainHQ
  • Behavioral: Interactive Trainer-Subject Sessions
    Other Names:
  • LearningRx
  • Active Comparator: Group + Computer B

    Daily activities involve group and individual cognitive therapy discussions on health, nutrition, and other topics and computer cognitive training B (CCB).

    Behavioral: Psycho-Social Therapy

    Device: Cognitive Behavioral Computer Training
    Other Names:
  • BrainHQ
  • Outcome Measures

    Primary Outcome Measures

    1. Composite performance score based on battery of neuropsychological tests of working memory, learning, memory, and executive function. [within one week following treatment completion]

      Composite performance score on neuropsychological battery based on four primary domains : learning, memory, working memory, and executive function.

    2. Participant reported outcomes [within one week following treatment completion.]

      Measure of impact of program use on the patient's own view of their impairment and function.

    3. Working/school status [within one week following treatment completion.]

      Measure of participants' employment status, and the number of hours worked/volunteered/in-school per week.

    4. Exercise-base assessments [within one week following treatment completion.]

      Four sets of assessments that are closely modeled on study-related exercises in the auditory, visual, cognitive, and social-cognitive modules. These include auditory speed of processing, visual speed of processing, cognitive control speed of processing and face recognition, recall of unique faces, and emotional cue recognition.

    5. Functional assessments [within one week following treatment completion.]

      Timed instrumental activities of daily living (TIADL) and the Mayo-Portland Adaptability Inventory (MPAI-4) for sensitive directly observed performance and well-accepted clinical impression measures.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 55 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • History of >1 Mild TBI: post traumatic amnesia/confusion ≤ 24 hour immediately after injury; or loss of consciousness <30 min confirmed by the Ohio State University TBI Identification Method-Short Form (OSU TBI-ID-SF).

    • Age 25-55 years

    • Minimum of 4 months post-injury

    • Adequate visual, auditory, sensory-motor function for training program.

    • Fluent in English

    • Persistent cognitive dysfunction confirmed by Ruff Neurobehavioral Inventory score of greater than 70 on any of the four cognitive scales (Attention, Memory, Language, Executive).

    Exclusion Criteria:
    • History of hypoxic event

    • Pre-existing significant neurological (e.g. MS) or psychiatric (e.g. schizophrenia, bi-polar) disorders.

    • Current illicit drug use or alcohol abuse

    • Unwilling or unable (e.g. language barrier) to participate

    • Hospitalization during study

    • Current Litigation

    • Positive on malingering test

    • Use of medications to enhance cognitive function (e.g. Ritalin)

    • Initial Glasgow Coma Score < 13 or penetrating head injury

    • Subjects must not show suicidal ideation as measured by the Columbia-Suicide Severity Rating Scale. Subjects with a score of 4 or 5 (as recommended by the FDA for treatment trials) will be excluded and referred for appropriate treatment.

    • Subjects should not be enrolled in a concurrent TBI clinical trial.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Brain & Body Health Institute, P.A. Lakeway Texas United States 78734

    Sponsors and Collaborators

    • Brain & Body Health Foundation

    Investigators

    • Principal Investigator: Robert W Van Boven, M.D., D.D.S., Brain & Body Health Foundation

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Robert W. Van Boven, M.D., D.D.S., Director, Brain & Body Health Foundation
    ClinicalTrials.gov Identifier:
    NCT02699476
    Other Study ID Numbers:
    • BBHF-001
    First Posted:
    Mar 4, 2016
    Last Update Posted:
    Mar 4, 2016
    Last Verified:
    Mar 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Robert W. Van Boven, M.D., D.D.S., Director, Brain & Body Health Foundation
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 4, 2016